Wolfgang Sippl
Pharmaceutical chemistry
Freiburg Institute for Advanced Studies
Germany
Biography
Wolfgang Sippl is Professor of Medical Chemistry and Director of the Institute of Pharmacy at the Martin-Luther-University Halle-Wittenberg. He studied Pharmacy at the FU Berlin from 1987 to 1991 and completed his doctorate with Prof. Hans-Dieter Höltje at the Heinrich-Heine-University Düsseldorf in the field of Pharmaceutical Chemistry with summa cum laude. After a one-year postdoctoral stay at the Université Louis-Pasteur in Strasbourg with Prof. Camille G. Wermuth, he returned to Düsseldorf, where he completed his Habilitation in Medical / Pharmaceutical Chemistry there in 2002. In 2001, he received the Innovation Prize for Pharmaceutical / Medical Chemistry from Gesellschaft Deutscher Chemiker and the German Pharmaceutical Society. In 2003 he received a professorship for medical chemistry at the Martin-Luther-University in Halle.
Research Interest
His research areas include computer-based drug design and the development of lead structures for epigenetic targets.
Publications
-
S. Brown, M. Brown, M. Brown, M. Brown, M. Brown, M. Brown, M. Brown, M. Brown biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors . Bioorg. Med. Chem. 2011, Feb. 2 [Epub ahead of print].
-
S. Caram, S. Caram, S. Caram, C. Caram, S. Caram, S. Caram, S. Caram, S. Caram, S. Caram, A. Carotta and S. Sampl: Carbamate prodrug concept for hydroxamate HDAC inhibitors . Chem. Med. Chem., 2011, March 17, doi: 10.1002 / cmdc.201100007.
-
W. Sippl, V. Collura, F. Colland: Ubiquitin specific proteases as cancer drug targets . Future Oncology 7, 619-32, 2011.
